Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money
An early deal with Merck was scotched for fear poor countries would be left out; now the university could make over $100 million with AstraZeneca if the technology succeeds.
An early deal with Merck was scotched for fear poor countries would be left out; now the university could make over $100 million with AstraZeneca if the technology succeeds.
The COVID-19 pandemic demands an urgent and unprecedented response. University research and expertise is critical ...
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a
Tennis fans show support for vaccine scientists and keyworkers on first day at Centre Court
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a
The COVID-19 pandemic demands an urgent and unprecedented response. University research and expertise is critical ...
以上內容由「Cofacts 真的假的」訊息回報機器人與查證協作社群提供,以 CC授權 姓名標示-相同方式分享 4.0 (CC BY-SA 4.0) 釋出,於後續重製或散布時,原社群顯名及每一則查證的出處連結皆必須被完整引用。